UH
WST icon

Unigestion Holding’s West Pharmaceutical WST Stock Holding History

Unigestion Holding’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,196
Closed -$552K – 229
2022
Q3 		$552K Hold
2,196
– – 0.03% 163
2022
Q2 		$664K Sell
2,196
-672
-23% -$219K 0.04% 162
2022
Q1 		$1.18M Sell
2,868
-82
-3% -$32.1K 0.05% 126
2021
Q4 		$1.38M Buy
2,950
+2,095
+245% +$902K 0.06% 115
2021
Q3 		$370K Sell
855
-2,336
-73% -$985K 0.02% 176
2021
Q2 		$1.15M Sell
3,191
-250
-7% -$82.6K 0.04% 144
2021
Q1 		$970K Buy
+3,441
New +$985K 0.03% 154

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Unigestion Holding's WST Position: Q4 2022 in Review

Unigestion Holding sold out of West Pharmaceutical (WST) in Q4 2022, closing a stake of 2,196 shares — an estimated $552K sold.

Unigestion Holding first reported a position in WST in Q1 2021 and held it in 7 quarters. The position peaked at $1.38M in Q4 2021. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • Unigestion Holding reported no remaining West Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Unigestion Holding sold 2,196 West Pharmaceutical shares in Q4 2022, an estimated $552K.
  • Unigestion Holding first reported a position in West Pharmaceutical in Q1 2021 and held it in 7 quarters.
  • Unigestion Holding's West Pharmaceutical position peaked at $1.38M in Q4 2021.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Unigestion Holding's 13F filing for Q4 2022, filed 13 Feb 2023.